These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 8649610)
41. Treatment of status epilepticus in children. Camfield PR Can Med Assoc J; 1983 Mar; 128(6):671-2. PubMed ID: 6825031 [TBL] [Abstract][Full Text] [Related]
42. Safety and tolerance of multiple doses of intramuscular fosphenytoin substituted for oral phenytoin in epilepsy or neurosurgery. Wilder BJ; Campbell K; Ramsay RE; Garnett WR; Pellock JM; Henkin SA; Kugler AR Arch Neurol; 1996 Aug; 53(8):764-8. PubMed ID: 8759983 [TBL] [Abstract][Full Text] [Related]
43. Cardiac arrest after fast intravenous infusion of phenytoin mistaken for fosphenytoin. DeToledo JC; Lowe MR; Rabinstein A; Villaviza N Epilepsia; 2001 Feb; 42(2):288. PubMed ID: 11240605 [No Abstract] [Full Text] [Related]
44. [Antiepileptic emergency therapy in the adult age]. Passarge C Dtsch Med Wochenschr; 1978 Oct; 103(42):1639-41. PubMed ID: 699782 [No Abstract] [Full Text] [Related]
45. Nose-to-brain delivery of phenytoin and its hydrophilic prodrug fosphenytoin combined in a microemulsion - formulation development and in vivo pharmacokinetics. Pires PC; Fazendeiro AC; Rodrigues M; Alves G; Santos AO Eur J Pharm Sci; 2021 Sep; 164():105918. PubMed ID: 34174414 [TBL] [Abstract][Full Text] [Related]
47. Intramuscular fosphenytoin (Cerebyx) in patients requiring a loading dose of phenytoin. Ramsay RE; Wilder BJ; Uthman BM; Garnett WR; Pellock JM; Barkley GL; Leppik IE; Knapp LE Epilepsy Res; 1997 Oct; 28(3):181-7. PubMed ID: 9332883 [TBL] [Abstract][Full Text] [Related]
48. Lacosamide in status epilepticus: Update on the TRENdS study. Husain AM Epilepsy Behav; 2015 Aug; 49():337-9. PubMed ID: 26152818 [TBL] [Abstract][Full Text] [Related]
49. Emergency management of the patient with seizures. 1. Generalized status epilepticus. Conomy JP; McNamara JO Postgrad Med; 1974 Feb; 55(2):71-4. PubMed ID: 4810254 [No Abstract] [Full Text] [Related]
50. [Acute poisoning with phenytoin caused by an error in the administration of fosphenytoin (Prodilantin)]. Presutti M; Pollet L; Stordeur JM; Bruder N; Gouin F Ann Fr Anesth Reanim; 2000 Nov; 19(9):688-90. PubMed ID: 11244710 [TBL] [Abstract][Full Text] [Related]
51. Epilepsy emergencies: the first seizure and status epilepticus. Willmore LJ Neurology; 1998 Nov; 51(5 Suppl 4):S34-8. PubMed ID: 9818922 [TBL] [Abstract][Full Text] [Related]
52. Additional modalities for treating acute seizures in children: overview. Bebin EM J Child Neurol; 1998 Oct; 13 Suppl 1():S23-6; discussion S30-2. PubMed ID: 9796749 [TBL] [Abstract][Full Text] [Related]
53. Impact of Obesity on Fosphenytoin Volume of Distribution in Pediatric Patients. Prusakov AB; Patel AD; Cole JW J Child Neurol; 2018 Jul; 33(8):534-536. PubMed ID: 29714095 [TBL] [Abstract][Full Text] [Related]
54. Falsely increased immunoassay measurements of total and unbound phenytoin in critically ill uremic patients receiving fosphenytoin. Roberts WL; De BK; Coleman JP; Annesley TM Clin Chem; 1999 Jun; 45(6 Pt 1):829-37. PubMed ID: 10351992 [TBL] [Abstract][Full Text] [Related]
57. Fosphenytoin for the treatment of status epilepticus: an evidence-based assessment of its clinical and economic outcomes. Thomson A Core Evid; 2005; 1(1):65-75. PubMed ID: 22496677 [TBL] [Abstract][Full Text] [Related]
58. Treatment of status epilepticus in children. De Negri M; Baglietto MG Paediatr Drugs; 2001; 3(6):411-20. PubMed ID: 11437186 [TBL] [Abstract][Full Text] [Related]